Skip to content
MunafaPlus

GLAXO — GlaxoSmithKline Pakistan Limited is

PHARMACEUTICALS

Plain English Verdict

Lower risk

This stock appears reasonably valued, strong profitability (high ROE).

Not financial advice. Always do your own research before investing.

52-Week Range

Rs 283.89
Rs 444.85

Current: Rs 376.11 (57.3% of range)

Health Check

P/E Ratio

12.4

Fair

ROE

32.4%

Strong

Div Yield

4.4%

P/B Ratio

3.69

EPS31.48
Debt/Equity1%
Gross Margin35%
Net Margin15%
Current Ratio2.32

30-Day Price